Literature DB >> 15113891

Susceptibility of cell populations to transduction by retroviral vectors.

Simon Wotherspoon1, Alla Dolnikov, Geoff Symonds, Robert Nordon.   

Abstract

Retroviral transduction efficiency is related to the multiplicity of infection and the physiological state of the target cells. It is generally not known what proportion of a cell population is susceptible to transduction. We used coinfection with two retroviral vectors containing the marker genes for green fluorescent protein and the truncated human nerve growth factor receptor. In the CD34+ cell line TF-1 or human primary CD34+ hematopoietic progenitor cells, it was found that cells transduced with one vector had a better than random chance of transduction by the other vector. A probability model was developed to estimate target cell susceptibility; susceptibility was calculated as the product of the proportions of transgene-positive cells divided by the proportion of double-positive cells. By using this relationship, it was found that susceptibility was related to the target cell type and culture conditions but not the retroviral titer or the retroviral packaging envelope protein used in this study. Cotransduction with two vectors is a relatively simple procedure that provides a means to assess the maximum transduction level possible in a given cell population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15113891      PMCID: PMC400332          DOI: 10.1128/jvi.78.10.5097-5102.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

Review 1.  Gene transfer technology in therapy: current applications and future goals.

Authors:  G Romano; C Pacilio; A Giordano
Journal:  Stem Cells       Date:  1999       Impact factor: 6.277

2.  Retroviral preparations derived from PA317 packaging cells contain inhibitors that copurify with viral particles and are devoid of viral vector RNA.

Authors:  J Seppen; S Barry; G M Lam; N Ramesh; W R Osborne
Journal:  Hum Gene Ther       Date:  2000-03-20       Impact factor: 5.695

3.  A comparative evaluation of gene transfer into blood cells using the same retroviral backbone for independent expression of the EGFP and deltaLNGFR marker genes.

Authors:  I Giaretta; D Madeo; R Bonaguro; A Cappellari; F Rodeghiero; P Giorgio
Journal:  Haematologica       Date:  2000-07       Impact factor: 9.941

4.  Four-color flow cytometric detection of retrovirally expressed red, yellow, green, and cyan fluorescent proteins.

Authors:  T S Hawley; W G Telford; A Ramezani; R G Hawley
Journal:  Biotechniques       Date:  2001-05       Impact factor: 1.993

5.  Rapid screening for high-titer retroviral packaging cell lines using an in situ fluorescence assay.

Authors:  Bronwyn J Green; John E J Rasko
Journal:  Hum Gene Ther       Date:  2002-06-10       Impact factor: 5.695

6.  Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection.

Authors:  D G Miller; M A Adam; A D Miller
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

7.  Single-step, multiple retroviral transduction of human T cells.

Authors:  José Luis Abad; Fernando Serrano; Ascensión L San Román; Rafael Delgado; Antonio Bernad; Manuel A González
Journal:  J Gene Med       Date:  2002 Jan-Feb       Impact factor: 4.565

8.  Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.

Authors:  A D Miller; C Buttimore
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

9.  Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin.

Authors:  T Kitamura; T Tange; T Terasawa; S Chiba; T Kuwaki; K Miyagawa; Y F Piao; K Miyazono; A Urabe; F Takaku
Journal:  J Cell Physiol       Date:  1989-08       Impact factor: 6.384

10.  Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus.

Authors:  A D Miller; J V Garcia; N von Suhr; C M Lynch; C Wilson; M V Eiden
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

View more
  7 in total

1.  Transduction efficiency of pantropic retroviral vectors is controlled by the envelope plasmid to vector plasmid ratio.

Authors:  Yong Chen; William M Miller; Ashok Aiyar
Journal:  Biotechnol Prog       Date:  2005 Jan-Feb

Review 2.  Delivery of nucleic acid therapeutics by genetically engineered hematopoietic stem cells.

Authors:  Christopher B Doering; David Archer; H Trent Spencer
Journal:  Adv Drug Deliv Rev       Date:  2010-09-30       Impact factor: 15.470

3.  Engineered Hematopoietic Stem Cells as Therapeutics for Hemophilia A.

Authors:  Philip M Zakas; H Trent Spencer; Christopher B Doering
Journal:  J Genet Syndr Gene Ther       Date:  2011-11-16

4.  Pharmacodynamics of anti-HIV gene therapy using viral vectors and targeted endonucleases.

Authors:  Pavitra Roychoudhury; Harshana S De Silva Feelixge; Harlan L Pietz; Daniel Stone; Keith R Jerome; Joshua T Schiffer
Journal:  J Antimicrob Chemother       Date:  2016-04-18       Impact factor: 5.790

5.  Improved coinfection with amphotropic pseudotyped retroviral vectors.

Authors:  Yuehong Wu; David W Melton; Yong Zhang; Peter J Hornsby
Journal:  J Biomed Biotechnol       Date:  2009-05-25

Review 6.  Targeted Cellular Micropharmacies: Cells Engineered for Localized Drug Delivery.

Authors:  Thomas J Gardner; Christopher M Bourne; Megan M Dacek; Keifer Kurtz; Manish Malviya; Leila Peraro; Pedro C Silberman; Kristen C Vogt; Mildred J Unti; Renier Brentjens; David Scheinberg
Journal:  Cancers (Basel)       Date:  2020-08-05       Impact factor: 6.639

7.  Critical factors for lentivirus-mediated PRDX4 gene transfer in the HepG2 cell line.

Authors:  Afiah Nasuha Aznan; Norwahidah Abdul Karim; Wan Zurinah Wan Ngah; Zakiah Jubri
Journal:  Oncol Lett       Date:  2018-05-07       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.